FDA Center for Drug Evaluation Director-designate Carl Peck
Executive Summary
Official announcement of Peck's appointment is pending HHS clearance of the Federal Register statement on the split of the Office of Drugs & Biologics. Peck's appointment has apparently been cleared; top FDAers are introducing him as the new drug division director. A formal public introduction is tentatively set for Oct. 19.